R.H. Bluestein & Co’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$315K Hold
7,100
0.02% 231
2022
Q2
$345K Hold
7,100
0.02% 217
2022
Q1
$447K Sell
7,100
-1,680
-19% -$99.8K 0.02% 212
2021
Q4
$584K Hold
8,780
0.02% 191
2021
Q3
$426K Buy
8,780
+1,000
+13% +$48.6K 0.02% 244
2021
Q2
$371K Sell
7,780
-1,000
-11% -$46.3K 0.01% 279
2021
Q1
$407K Buy
8,780
+1,000
+13% +$46.2K 0.02% 244
2020
Q4
$341K Sell
7,780
-5,000
-39% -$195K 0.02% 252
2020
Q3
$466K Sell
12,780
-4,000
-24% -$134K 0.02% 171
2020
Q2
$530K Buy
16,780
+2,000
+14% +$56K 0.03% 143
2020
Q1
$350K Sell
14,780
-5,750
-28% -$162K 0.03% 154
2019
Q4
$649K Buy
20,530
+4,580
+29% +$139K 0.03% 127
2019
Q3
$440K Buy
+15,950
New +$453K 0.02% 167
2015
Q3
Sell
-100,000
Closed -$1.33M 304
2015
Q2
$1.33M Hold
100,000
0.08% 77
2015
Q1
$1.27M Hold
100,000
0.08% 78
2014
Q4
$1.01M Sell
100,000
-100,000
-50% -$893K 0.06% 98
2014
Q3
$1.74M Buy
200,000
+150,000
+300% +$1.17M 0.11% 75
2014
Q2
$360K Buy
+50,000
New +$336K 0.02% 246

Other funds holding AVGO

R.H. Bluestein & Co's AVGO Position: Q3 2022 in Review

R.H. Bluestein & Co held its Broadcom (AVGO) position steady in Q3 2022 at 7,100 shares worth $315K. The position accounts for 0.02% of the portfolio, ranked #231.

R.H. Bluestein & Co first reported a position in AVGO in Q2 2014 and has held it in 18 quarters since. The position peaked at $1.74M in Q3 2014. 2,010 funds tracked by Wall St. Rank hold AVGO as of Q3 2022.

  • R.H. Bluestein & Co held 7,100 shares of Broadcom worth $315K as of Q3 2022.
  • R.H. Bluestein & Co left its Broadcom share count unchanged in Q3 2022.
  • Broadcom made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #231 holding.
  • R.H. Bluestein & Co first reported a position in Broadcom in Q2 2014 and has held it in 18 quarters since.
  • R.H. Bluestein & Co's Broadcom position peaked at $1.74M in Q3 2014.
  • 2,010 funds tracked by Wall St. Rank held Broadcom as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.